A groundbreaking MIT study published in Nature offers new insights into the cellular mechanisms underlying Alzheimer’s disease, revealing potential targets for interventions to maintain cognitive function.
Scientists in the UK have developed the first code of practice for research using stem cell-based embryo models, providing ethical guidelines and governance for this rapidly advancing field.
A groundbreaking gene therapy for Duchenne muscular dystrophy (DMD) has demonstrated significant potential in not only arresting muscle decline but also possibly repairing damaged muscle tissue. This novel treatment, developed by researchers at UW Medicine, utilises a series of protein packets delivered via viral vectors to replace the defective DMD gene within affected muscles.
Research from Mass Eye and Ear demonstrates successful use of CRISPR/Cas9 to target and disrupt a genetic mutation causing hearing loss, offering hope for future treatments in humans.
New research from Johns Hopkins University expands our understanding of genetic variation across diverse populations, potentially improving the accuracy of genetic predictions and personalised medicine.
Researchers have developed a novel gene-editing approach that efficiently corrects the most common cystic fibrosis mutation, potentially paving the way for a one-time, permanent treatment with fewer side effects than current therapies.
A groundbreaking study has unveiled a novel genetic factor contributing to obesity, shedding light on the complex interplay between genetics and body weight regulation.
April 2024
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Tsai Lab/ MIT Picower Institute
Irene Zorzan and Teresa Rayon, Babraham Institute
Chamberlain Lab